Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MLAB | FTV |
|---|---|---|
| Price | $129.96 | $56.52 |
| Change today | ▼ 4.48% | ▼ 2.37% |
| Market cap | $727.24M | $17.07B |
| Return, 3 months | +36.4% | -7.5% |
| Return, year to date | +66.3% | +2.7% |
| Return, 1 year | +84.9% | +13.9% |
| P/E (TTM) | 152.9 | 33.4 |
| P/B | 3.9 | 2.8 |
| P/E percentile vs own 5y | 67th | 58th |
| Dividend yield | 0.49% | 0.42% |
| Revenue growth (YoY, latest qtr) | +1.0% | +7.9% |
| Net profit growth (YoY) | -40.3% | -5.6% |
| Gross margin | 64.2% | 63.2% |
| Operating margin | 9.0% | 18.2% |
| Net margin | 1.9% | 12.4% |
| Return on equity | 2.7% | 6.5% |
| Analyst target vs. price | – | +15.6% |
| Analyst buy share | – | 25% |
| RSI (14) | 51 | 49 |
| 30-day volatility | 42.5% | 23.6% |
| Max drawdown, 1 year | -24.2% | -14.8% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
